A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome

Neurology

Volumn 52, Issue 9, 1999, Pages 1882-1887

  Sachdeo, R C ^a,f   Glauser, T A ^b   Ritter, F ^c   Reife, R ^d   Lim, P ^e   Pledger, G ^e  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b JOHNSON AND JOHNSON   (United States)

^c R W JOHNSON PHARMACEUTICAL RES I   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e MINNESOTA EPILEPSY GROUP   (United States)

^f ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOPIRAMATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CLEARANCE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LENNOX GASTAUT SYNDROME; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEIZURE; TONIC SEIZURE; TREATMENT OUTCOME;

EID: 0032976081     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.9.1882     Document Type: Article

References (21)

1. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30:389-399.
2. Commission on Antiepileptic Drugs of the International League Against Epilepsy. Guidelines for antiepileptic drug trials in children. Epilepsia 1994;35:94-100.
3. The Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993;328:29-33.
4. Motte J, Trevathan E, Arvidsson JFV, et al. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl J Med 1997;337:1807-1812.
5. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increase seizure threshold. Epilepsy Res 1997;27:167-179.
6. Ben-Menachem E, Henriksen O, Dam M, et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 1996;37: 539-543.
7. Faught E, Wilder BJ, Ramsay RE, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Neurology 1996;46: 1684-1690.
8. Privitera M, Fincham R, Penry J, et al. Topiramate placebocontrolled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Neurology 1996; 46:1678-1683.
9. Sharief M, Viteri C, Ben-Menachem E, et al. Double-blind, placebo-controlled study of topiramate in patients with refractory epilepsy. Epilepsy Res 1996;25:217-224.
10. Tassinari CA, Michelucci R, Chauvel P, et al. Double-blind, placebo-controlled of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 1996;37:763768.
11. Bourgeois BFD. New antiepileptic drugs. Arch Neurol 1998; 55:1181-1183.
12. Pennell PB, Ogaily MS, Macdonald RL. Aplastic anemia in a patient receiving felbamate for complex partial seizures. Neurology 1995;45:456-460. .
13. Capizzi T, Zhang J. Testing the hypothesis that matters for multiple primary endpoints. Drug Info J 1996;30:949-956.
14. Conover WJ, Iman RL. Rank transformations as a bridge between parametric and nonparametric statistics. Am Stat 1981;35:124-129.
15. SAS/STAT users guide: version 6. 4th éd. Cary, NC: SAS Institute, Inc., May 1992.
16. Lehmann EL. Nonparametrics: statistical methods based on ranks. San Francisco: Holden Day, 1975.
17. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: John Wiley & Sons, 1981:173-175.
18. Ikeno T, Shigematsu H, Miyakoshi M, Ohba A, Yagi K, Seino M. An analytic study of epileptic falls. Epilepsia 1985; 26:612-621.
19. Aicardi J. Epilepsy in children. 2nd ed. New York; Raven Press, 1994:44-66.
20. Langtry HD, Wagstaff AJ. Management of epilepsy: defining the role of lamotrigine. Dis Manage Health Outcomes 1997;!: 254-270.
21. Rosenfeld WE. Topiramate: a review of preclinical, pharmacokinetic, and clinical data. Clin Ther 1997;19:1294-1308.